CN1193102C - 黑皮质素－4受体基因及其作为动物脂肪含量、体重增加和/或饲料消耗的遗传标记的用途 - Google Patents
黑皮质素－4受体基因及其作为动物脂肪含量、体重增加和/或饲料消耗的遗传标记的用途 Download PDFInfo
- Publication number
- CN1193102C CN1193102C CNB998111139A CN99811113A CN1193102C CN 1193102 C CN1193102 C CN 1193102C CN B998111139 A CNB998111139 A CN B998111139A CN 99811113 A CN99811113 A CN 99811113A CN 1193102 C CN1193102 C CN 1193102C
- Authority
- CN
- China
- Prior art keywords
- polymorphism
- mc4r
- animal
- gene
- ile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 65
- 239000003550 marker Substances 0.000 title claims abstract description 27
- 230000002068 genetic effect Effects 0.000 title claims abstract description 18
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 title abstract description 84
- 230000004584 weight gain Effects 0.000 title description 3
- 235000019786 weight gain Nutrition 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 71
- 230000012010 growth Effects 0.000 claims abstract description 35
- 238000009395 breeding Methods 0.000 claims abstract description 12
- 230000001488 breeding effect Effects 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 60
- 101150110867 MC4R gene Proteins 0.000 claims description 32
- 108020004414 DNA Proteins 0.000 claims description 29
- 239000012634 fragment Substances 0.000 claims description 25
- 230000008859 change Effects 0.000 claims description 21
- 150000001413 amino acids Chemical class 0.000 claims description 20
- 235000021050 feed intake Nutrition 0.000 claims description 19
- 235000013305 food Nutrition 0.000 claims description 19
- 238000004458 analytical method Methods 0.000 claims description 18
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims description 17
- 239000002773 nucleotide Substances 0.000 claims description 14
- 125000003729 nucleotide group Chemical group 0.000 claims description 14
- 230000029087 digestion Effects 0.000 claims description 12
- 150000002632 lipids Chemical class 0.000 claims description 11
- 230000002503 metabolic effect Effects 0.000 claims description 9
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 8
- 108020004705 Codon Proteins 0.000 claims description 7
- 108091008146 restriction endonucleases Proteins 0.000 claims description 7
- 230000003321 amplification Effects 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 claims description 3
- 235000004213 low-fat Nutrition 0.000 claims description 3
- 108700028369 Alleles Proteins 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 238000000123 temperature gradient gel electrophoresis Methods 0.000 claims 3
- 125000003473 lipid group Chemical group 0.000 claims 2
- 108091027305 Heteroduplex Proteins 0.000 claims 1
- 101000978418 Homo sapiens Melanocortin receptor 4 Proteins 0.000 claims 1
- 102100023724 Melanocortin receptor 4 Human genes 0.000 claims 1
- 102000001796 Melanocortin 4 receptors Human genes 0.000 abstract description 80
- 238000012360 testing method Methods 0.000 abstract description 43
- 230000008901 benefit Effects 0.000 abstract description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 61
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 51
- 241000282898 Sus scrofa Species 0.000 description 44
- 238000003752 polymerase chain reaction Methods 0.000 description 39
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 33
- 239000000047 product Substances 0.000 description 23
- 241000282414 Homo sapiens Species 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 18
- 102220023257 rs387907546 Human genes 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 102000004378 Melanocortin Receptors Human genes 0.000 description 14
- 108090000950 Melanocortin Receptors Proteins 0.000 description 14
- 101100129533 Sus scrofa MC4R gene Proteins 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 13
- 229940024606 amino acid Drugs 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 230000035772 mutation Effects 0.000 description 12
- 241000282887 Suidae Species 0.000 description 11
- 239000000370 acceptor Substances 0.000 description 10
- 238000009396 hybridization Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 208000008589 Obesity Diseases 0.000 description 7
- 241000831652 Salinivibrio sharmensis Species 0.000 description 7
- 235000020997 lean meat Nutrition 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 102000016267 Leptin Human genes 0.000 description 6
- 108010092277 Leptin Proteins 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 229940039781 leptin Drugs 0.000 description 6
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 102100029464 Aquaporin-9 Human genes 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
- 101000771413 Homo sapiens Aquaporin-9 Proteins 0.000 description 5
- 101000921370 Homo sapiens Elongation of very long chain fatty acids protein 1 Proteins 0.000 description 5
- 235000003704 aspartic acid Nutrition 0.000 description 5
- 230000003542 behavioural effect Effects 0.000 description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 5
- 102220369445 c.668T>C Human genes 0.000 description 5
- 238000013016 damping Methods 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 235000013622 meat product Nutrition 0.000 description 5
- 108010008364 Melanocortins Proteins 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000019439 energy homeostasis Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002865 melanocortin Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000003760 tallow Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 102220023256 rs387907547 Human genes 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 2
- 108010072151 Agouti Signaling Protein Proteins 0.000 description 2
- 102000006822 Agouti Signaling Protein Human genes 0.000 description 2
- 241000484025 Cuniculus Species 0.000 description 2
- 241000701149 Human adenovirus 1 Species 0.000 description 2
- 102400000064 Neuropeptide Y Human genes 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 239000009466 Valverde Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 102220369446 c.1274G>A Human genes 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000004146 energy storage Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000003234 polygenic effect Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 108010030587 rat melanocortin receptor type 4 Proteins 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 102220004457 rs11567847 Human genes 0.000 description 2
- 102220023258 rs387907548 Human genes 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102100032539 Calpain-3 Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001155433 Centrarchus macropterus Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 101000867715 Homo sapiens Calpain-3 Proteins 0.000 description 1
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
- 229940126661 MC4 antagonist Drugs 0.000 description 1
- 108010018650 MEF2 Transcription Factors Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
- 102100021148 Myocyte-specific enhancer factor 2A Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 101800003845 Neuropeptide Y Proteins 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 101001022382 Sus scrofa Leptin Proteins 0.000 description 1
- 101000687489 Sus scrofa Prolactin Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002922 epistatic effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010359 gene isolation Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000037434 nonsense mutation Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- -1 nucleoside triphosphates Chemical class 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 102200094959 rs2229616 Human genes 0.000 description 1
- 102220095038 rs876660955 Human genes 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 108010056545 swine leukocyte antigen Proteins 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9428798P | 1998-07-27 | 1998-07-27 | |
| US11618699P | 1999-01-15 | 1999-01-15 | |
| US60/116,186 | 1999-01-15 | ||
| US60/094,287 | 1999-01-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1328602A CN1328602A (zh) | 2001-12-26 |
| CN1193102C true CN1193102C (zh) | 2005-03-16 |
Family
ID=26788709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB998111139A Expired - Fee Related CN1193102C (zh) | 1998-07-27 | 1999-07-26 | 黑皮质素－4受体基因及其作为动物脂肪含量、体重增加和/或饲料消耗的遗传标记的用途 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1100970A2 (es) |
| JP (1) | JP3790102B2 (es) |
| CN (1) | CN1193102C (es) |
| AU (1) | AU758179B2 (es) |
| BR (1) | BR9912460A (es) |
| CA (1) | CA2337495C (es) |
| HU (1) | HUP0102715A3 (es) |
| MX (1) | MXPA01001100A (es) |
| PL (1) | PL346223A1 (es) |
| WO (1) | WO2000006777A2 (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100591692C (zh) * | 2007-08-13 | 2010-02-24 | 中国农业科学院北京畜牧兽医研究所 | 一种猪脂肪沉积相关蛋白及其编码基因与应用 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002064091A2 (en) | 2001-02-13 | 2002-08-22 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
| US6803190B1 (en) | 1998-07-27 | 2004-10-12 | Iowa State University Research Foundation, Inc. | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
| CZ20023261A3 (cs) * | 2000-03-30 | 2003-02-12 | Iowa State University Research Foundation | Genetické markery pro zlepšené vlastnosti zvířecího masa |
| WO2001079222A2 (en) * | 2000-04-12 | 2001-10-25 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the mc4r gene |
| US20030032791A1 (en) * | 2000-06-26 | 2003-02-13 | Alan Robertson Scott | Novel melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| KR100427645B1 (ko) * | 2001-07-24 | 2004-04-28 | 한국생명공학연구원 | 인간 멜라노코틴-4 수용체에 대한 항체와 그 제조방법 |
| CA2387003A1 (en) * | 2002-05-21 | 2003-11-21 | 984012 Alberta Ltd. | Method for improving efficiencies in livestock production |
| WO2004061125A2 (en) | 2002-12-31 | 2004-07-22 | Mmi Genomics, Inc. | Compositions, methods and systems for inferring bovine traits |
| ES2877349T3 (es) * | 2005-07-08 | 2021-11-16 | Ipsen Pharma | Ligandos de los receptores de la melanocortina |
| EP2230944B1 (en) | 2007-11-29 | 2017-01-04 | Monsanto Technology, LLC | Meat products with increased levels of beneficial fatty acids |
| CN103923997B (zh) * | 2014-04-21 | 2016-09-07 | 广西壮族自治区水牛研究所 | 水牛产奶性状mc4r基因的克隆及作为分子标记的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5940198A (en) * | 1995-12-22 | 1999-08-17 | U.S. Philips Corporation | Optical unit for synchronizing clock signals |
| US5932779A (en) * | 1996-06-10 | 1999-08-03 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
-
1999
- 1999-07-26 HU HU0102715A patent/HUP0102715A3/hu unknown
- 1999-07-26 WO PCT/US1999/016862 patent/WO2000006777A2/en active IP Right Grant
- 1999-07-26 EP EP99937474A patent/EP1100970A2/en not_active Withdrawn
- 1999-07-26 BR BR9912460-2A patent/BR9912460A/pt not_active IP Right Cessation
- 1999-07-26 MX MXPA01001100A patent/MXPA01001100A/es not_active Application Discontinuation
- 1999-07-26 CA CA002337495A patent/CA2337495C/en not_active Expired - Lifetime
- 1999-07-26 JP JP2000562559A patent/JP3790102B2/ja not_active Expired - Fee Related
- 1999-07-26 PL PL99346223A patent/PL346223A1/xx not_active Application Discontinuation
- 1999-07-26 AU AU52301/99A patent/AU758179B2/en not_active Ceased
- 1999-07-26 CN CNB998111139A patent/CN1193102C/zh not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100591692C (zh) * | 2007-08-13 | 2010-02-24 | 中国农业科学院北京畜牧兽医研究所 | 一种猪脂肪沉积相关蛋白及其编码基因与应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01001100A (es) | 2002-08-20 |
| CN1328602A (zh) | 2001-12-26 |
| HUP0102715A3 (en) | 2004-10-28 |
| WO2000006777A2 (en) | 2000-02-10 |
| AU758179B2 (en) | 2003-03-20 |
| JP3790102B2 (ja) | 2006-06-28 |
| HUP0102715A2 (en) | 2002-09-28 |
| AU5230199A (en) | 2000-02-21 |
| EP1100970A2 (en) | 2001-05-23 |
| PL346223A1 (en) | 2002-01-28 |
| WO2000006777A3 (en) | 2000-05-11 |
| CA2337495C (en) | 2008-03-18 |
| BR9912460A (pt) | 2002-02-13 |
| CA2337495A1 (en) | 2000-02-10 |
| JP2002521068A (ja) | 2002-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1483081A (zh) | 新的prkag3等位基因及其作为生殖和肉质性状的遗传标记的应用 | |
| CN100351393C (zh) | 核苷酸多态性的检测方法 | |
| CN1806051A (zh) | 通过(例如)t细胞受体v/d/j基因中的重复鉴定克隆性细胞 | |
| CN1257551A (zh) | Vntr等位基因的提取与利用 | |
| CN1193102C (zh) | 黑皮质素－4受体基因及其作为动物脂肪含量、体重增加和/或饲料消耗的遗传标记的用途 | |
| CN1263559A (zh) | 分析动物产品的方法 | |
| CN1876843A (zh) | 检测突变和/或多态性的方法 | |
| CN1497049A (zh) | 雄激素受体复合物-相关蛋白 | |
| CN1646701A (zh) | 用于证实遗传身份的方法和测试试剂盒 | |
| CN1643162A (zh) | 新的hmga等位基因及作为生长、脂肪量、肉质及饲料消耗比性状遗传标记的应用 | |
| CN1496410A (zh) | 方法 | |
| CN1351671A (zh) | 一种基于转座子的新型遗传标记 | |
| CN1668635A (zh) | 新钙蛋白酶抑制蛋白(cast)等位基因 | |
| CN1503847A (zh) | 用于鉴定牛脊椎畸形综合征携带者的遗传试验 | |
| CN1635142A (zh) | 用于预测偏执型精神分裂症易感性的试剂盒及所用引物 | |
| CN1671841A (zh) | 基因多态性分型方法 | |
| CN1211486C (zh) | 编码前神经肽y原突变体,一种信号肽的突变体,的dna分子及其应用 | |
| CN1496402A (zh) | 表达基因鉴定用cDNA标记物的制备方法和基因表达分析方法 | |
| CN1170850C (zh) | 人血管生成素样蛋白和编码序列及其用途 | |
| CN1708589A (zh) | Cns中crh应答基因 | |
| CN1958605A (zh) | Spg3a基因突变、其编码产物及其应用 | |
| CN1777683A (zh) | 在动物中鉴别遗传性状的方法 | |
| CN1771337A (zh) | 包含单核苷酸多态性且与结肠癌有关的多核苷酸、包括该多核苷酸的微阵列和诊断试剂盒以及用该多核苷酸诊断结肠癌的方法 | |
| CN1606622A (zh) | 通过全面检测和定量食物中毒细菌的热稳定直接溶血素相关的基因 ( t d h ) 相关溶血素基因)对产溶血素细菌进行检测和定量的方法 | |
| CN101033487A (zh) | 检测与原发性高血压相关的KLK1基因rs5517多态的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| C10 | Entry into substantive examination | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |